Physician profile
Robert E Arnsdorf
NPI 1184616401
$1,545.61
in general payments reported to CMS, 2019-2025
19 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $56.17 · 2021: $36.01 · 2022: $226 · 2023: $250 · 2024: $239 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788 · Education: $29.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.54 |
| Education | $29.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $196.74 | 2022-2025 | Dysport |
| Merz Pharmaceuticals, LLC | $164.68 | 2023-2025 | Xeomin |
| Relievant Medsystems, INC. | $148.89 | 2019 | |
| Si-Bone, INC. | $148.08 | 2020-2022 | |
| Boston Scientific Corporation | $140.77 | 2025 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $120.45 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $119.30 | 2019-2024 | Xtampza |
| Pfizer INC. | $119.10 | 2019-2025 | |
| Allergan, INC. | $63.42 | 2019 | |
| Bioventus LLC | $60.17 | 2023-2024 | Durolane, Durolane |
| Tanabe Pharma America, INC. | $49.87 | 2024 | |
| Vertical Pharmaceuticals, LLC | $37.07 | 2019 | |
| Abbvie INC. | $35.56 | 2022-2023 | Botox, Ubrelvy |
| Argenx US, INC. | $35.08 | 2024 | Vyvgart Hytrulo |
| Otto Bock Healthcare Lp | $29.10 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $24.92 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.82 | 2020 | |
| Scilex Pharmaceuticals INC. | $15.54 | 2019 | |
| Abbott Laboratories | $15.05 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Arnsdorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.